SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision

How can AQP4 be effectively targeted therapeutically to improve neurological outcomes in CNS disorders?

PARTIALLY ADDRESSED

While the abstract identifies AQP4 as a 'potential and promising target' and mentions it could provide 'new therapeutic alternatives,' the specific approaches for therapeutic modulation of AQP4 function are not defined. This represents a critical translational gap for moving from mechanistic understanding to clinical intervention. Gap type: open_question Source paper: Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders. (2023, Neurobiol Dis, PMID:36796590)

Priority: 0.82 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: How can AQP4 be effectively targeted therapeutically to improve neurological outcomes in CNS disorders? is a 0.82 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

How can AQP4 be effectively targeted therapeutically to improve neurological outcomes in CNS disorders? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (1)

AQP4→COMPLEMENT CASCADE

associated with (5)

AQP4→CSF-ISF ExchangeAQP4→Glymphatic SystemAQP4→Sepsis-Associated EncephalopathyAQP4→Neuromyelitis Optica Spectrum DisorderAQP4→NEUROMYELITIS OPTICA SPECTRUM DISORDER

binds (5)

AQP4→Aquaporin-4-IgGcalmodulin→AQP4IGG AUTOANTIBODY→AQP4AQP4-ANTIBODY→AQP4AQP4-Ab→AQP4

biomarker for (4)

AQP4→Neuromyelitis OpticaAQP4→NEUROMYELITIS OPTICA SPECTRUM DISORDERAQP4→NMOSDAQP4→Neuromyelitis Optica Spectrum Disorder

component of (2)

AQP4→Glymphatic PathwayAQP4→Glymphatic System

data in (1)

ds-f2c28aed24a7→AQP4

describes (1)

cell-types-nodes-ranvier-neurod→CNS

detects glymphatic dysfunction (1)

H5_AQP4→AQP4

encodes (1)

AQP4→AQP4

enhances function (1)

H2→AQP4

expressed in (3)

AQP4→Astrocytic EndfeetAQP4→Astrocyte EndfeetAQP4→Central Nervous System

implicated in (1)

AQP4→demyelination

inhibits (2)

AQP4→NF-κB PathwayAQP4→Astrocytic Autophagy

involved in (5)

AQP4→CNS edemaAQP4→Glymphatic PathwayAQP4→Glymphatic DysfunctionAQP4→GLYMPHATIC SYSTEMAQP4→Beta-Amyloid Clearance

mediates (8)

AQP4→glymphatic pathwayAQP4→Perivascular Water TransportAQP4→CSF-ISF ExchangeAQP4→Glymphatic ClearanceAQP4→Glymphatic Transport
▸ Show 3 more

promotes (1)

AQP4→brain edema

protects against (1)

AQP4→Tau Aggregation

provides data for (1)

AQP4→ds-f2c28aed24a7

regulates (4)

AQP4→Tau ClearanceAQP4→Amyloid Beta ClearanceAQP4→CHI3L1B Cells→AQP4

targets (1)

TGN-020→AQP4

upregulates (1)

Cecal Ligation and Perforation→AQP4
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps